EU initiates discussion on challenges facing devices sector
This article was originally published in SRA
The European Commission is inviting stakeholders to debate the most pressing issues currently facing the medtech sector1. The aim is to map public health and industrial challenges in the sector and identify topics that need further attention and action at the European level.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.